3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
17
Genitourinary
8
Other hematologic neoplasm
6
Classical hematology
6
CNS
3
Thoracic
2
Lymphoid
2
Endocrine
2
Sarcoma
1
Plasma cell
1
Myeloid
1
Gynecologic
1
Conditions
Myelodysplastic Syndromes
1349
Leukemia, Myeloid, Acute
1133
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
713
Leukemia
675
Precursor Cell Lymphoblastic Leukemia-Lymphoma
646
Myeloproliferative Disorders
527
Leukemia, Myelomonocytic, Chronic
424
Lymphoma, Non-Hodgkin
407
Primary Myelofibrosis
384
Multiple Myeloma
369
Leukemia, Lymphocytic, Chronic, B-Cell
367
Hodgkin Disease
348
Leukemia, Myeloid, Chronic-Phase
304
Lymphoma
291
Blast Crisis
256
Leukemia, Myeloid, Accelerated Phase
238
Lymphoma, Mantle-Cell
231
Lymphoma, Follicular
226
Burkitt Lymphoma
224
Polycythemia Vera
222
Lymphoma, Large B-Cell, Diffuse
219
Lymphoma, B-Cell, Marginal Zone
203
Congenital Abnormalities
192
Anemia, Refractory, with Excess of Blasts
187
Lymphoma, Large-Cell, Immunoblastic
182
Myelodysplastic-Myeloproliferative Diseases
175
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
173
Thrombocythemia, Essential
167
Neoplasms, Plasma Cell
161
Hematologic Neoplasms
161
Interventions
N(4)-oleylcytosine arabinoside
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hemorrhage
×
Myeloid
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled